Although IL-6 expression in early-stage breast carcinomas has been correlated with low grade, oestrogen receptor status and good prognosis (Fontanini et al, 1999; Karczewska et al, 2000), several studies have shown that IL-6 may contribute to disease progression, particularly in advanced breast cancer patients. The gene discussed is IL6; the disease is breast cancer.